Despite Just-In-Time (JIT) production often being the preferred approach in clinical trial supply, it has taken a global pandemic for many organizations to make it a reality. Now, as we look to the future, PRISYM ID’s Bob Bowdish explains why these practices may be here to stay.
17th February 2022
In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers. But there are still a handful of advertiser holdouts, and they are missing out on highly engaged audiences.
3rd November 2021
By Grace Oldham, Head of Business Development, at Axil Integrated Services
7th October 2021
How immersive learning experiences can support and elevate patient-centricity goals in the pharma industry
9th July 2021
Patient centricity that delivers the ‘triple win’ is a business essential for pharma
9th July 2021
Sue Thomas explains how Wilmington Healthcare's unique behavioural methodology is helping to define best practice pathways for patients with chronic kidney disease (CKD) during the pandemic
22nd June 2021
Steve How explains how Wilmington Healthcare's unique behavioural methodology is being used to map patient journeys across the integrated care landscape
13th May 2021
Life science companies were challenged by the sudden shift in ways of working as the COVID-19 pandemic began. But in moving critical work and even some large-scale events to virtual platforms, pharmaceutical teams learned valuable lessons and embraced new technologies that will become part of their long-term strategy.
11th May 2021
The COVID-19 pandemic has brought into question how we approach care across multiple disease areas in the future. But what does this mean in cancer? Hear from Bristol Myers Squibb’s (BMS) Executive Medical Director, Hubert Bland, who believes that in order to advance in cancer care, we must learn from the COVID-19 response and adopt a collaborative approach across the healthcare industry.
4th May 2021
